Systematics investigation of key drivers of lung adenocarcinoma: A focus on genes, pathways, and miRNAs

Maryam Navaei, Fatemeh Karami, Aria Jahanimoghadam, Sara Zareei, Babak Khorsand
doi: https://doi.org/10.1101/2024.11.09.24317046

Article Information

doi 
https://doi.org/10.1101/2024.11.09.24317046
History 
  • November 10, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Maryam Navaei1,
  2. Fatemeh Karami2,
  3. Aria Jahanimoghadam3,
  4. Sara Zareei4 and
  5. Babak Khorsand5,*
  1. 1Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
  2. 2Protein Research Center, Shahid Beheshti University, Tehran, Iran
  3. 3Biocenter, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074 Würzburg, Germany
  4. 4Department of Cell & Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran
  5. 5Department of Neurology, University of California, Irvine, CA, USA
  1. ↵*Corresponding author; email: khorsand.babak{at}uci.edu
Back to top
Posted November 10, 2024.
Download PDF
Data/Code
Email
Systematics investigation of key drivers of lung adenocarcinoma: A focus on genes, pathways, and miRNAs
Maryam Navaei, Fatemeh Karami, Aria Jahanimoghadam, Sara Zareei, Babak Khorsand
medRxiv 2024.11.09.24317046; doi: https://doi.org/10.1101/2024.11.09.24317046
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area